Sign in
ADPT Stock Price, Chart, Stats & News
Adaptive Biotechnologies Corporation
Save
3.35B
Market cap
–
Current P/E
–
Forward P/E
ADPT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 74.24% |
Operating margin | -20.62% |
Pretax margin | -21.47% |
Net margin | -21.48% |
Effective tax rate | – |
ROA | -11.60% |
ROE | -30.00% |
D/E | 1.28x |
Interest coverage ratio | -4.85x |
ADPT valuation
P/E | – |
P/S | 6.90x |
P/B | 8.69x |
P/CF | -41.32x |
P/FCF | -39.04x |
P/OCF | -41.32x |
PEG | -1.23x |
EV multiple | -45.65x |
About
Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a broad spectrum of illnesses. The company offers several core technological solutions.
Similar securities
Based on sector and market capitalization
Report issue